The Impact of The Rads Assessment- Can Fewer Injections With Intravitreal Aflibercept Translate To Lower Overall Treatment Burden and Costs In Wamd When Compared With Intravitreal Ranibizumab?
Oct 1, 2017, 00:00
10.1016/j.jval.2017.08.2388
https://www.valueinhealthjournal.com/article/S1098-3015(17)32722-5/fulltext
Title :
The Impact of The Rads Assessment- Can Fewer Injections With Intravitreal Aflibercept Translate To Lower Overall Treatment Burden and Costs In Wamd When Compared With Intravitreal Ranibizumab?
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(17)32722-5&doi=10.1016/j.jval.2017.08.2388
First page :
A802
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
2207